NCT06925282 Determinants of Rescue Ventilation Requirement in Airway Surgery Under General Anesthesia With THRIVE
| NCT ID | NCT06925282 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Subglottic Stenosis (SGS) |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-04-25 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2025-04-25 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The anesthesia and surgical procedures from the time the patient enters the operating room to discharge from the recovery room are identical to those used in conventional airway surgeries performed under general anesthesia with Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE). The time point at which rescue ventilation is required due to a drop in oxygen saturation below 92% during anesthesia will be recorded, and the predictive factors for this event will be investigated.
Eligibility Criteria
Inclusion Criteria: * Adult patients undergoing elective airway surgery under general anesthesia with Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) * Patients who provide written informed consent Exclusion Criteria: * Patients who decline to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06925282 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Subglottic Stenosis (SGS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06925282 currently recruiting?
Yes, NCT06925282 is actively recruiting participants. Contact the research team at skwskw126@gmail.com for enrollment information.
Where is the NCT06925282 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06925282 clinical trial?
NCT06925282 is sponsored by Seoul National University Hospital. The trial plans to enroll 80 participants.